PMID- 15690152 OWN - NLM STAT- MEDLINE DCOM- 20051017 LR - 20131121 IS - 0340-5761 (Print) IS - 0340-5761 (Linking) VI - 79 IP - 6 DP - 2005 Jun TI - Metabolites of benzene are potent inhibitors of gap-junction intercellular communication. PG - 303-11 AB - Chronic exposure to benzene has been shown to lead to bone marrow depression and the development of leukemia. The mechanism underlying the carcinogenicity of benzene is unknown, although a number of genetic changes including chromosomal aberrations have been associated with benzene toxicity. Metabolism of benzene is required for the induced toxicological effects. We have investigated the effect of trans,trans-muconaldehyde (MUC), hydroquinone (HQ), and four MUC metabolites on gap-junction intercellular communication (GJIC). Inhibition of GJIC has been considered a possible predictor of tumor promoters and non-genotoxic carcinogens, and shown to result in perturbation of hematopoiesis. MUC was found to be a strong inhibitor of GJIC (EC50=12 micromol L(-1)) in rat liver epithelial cells IAR20, with potency similar to that of chlordane (EC50=7 micromol L(-1)). HQ inhibited GJIC with an EC50 of 25 micromolmol L(-1), and the metabolite OH/CHO with an EC50 of 58 micromol L(-1). The other MUC metabolites tested, CHO/COOH and OH/COOH were weak inhibitors of GJIC whereas COOH/COOH had no effect. Benzene itself had no effect on GJIC when tested in concentrations up to 20 micromol L(-1). The relative potency observed for the metabolites on GJIC is similar to their hematotoxic effects. The effect of MUC on GJIC was observed to take place concordant with a dramatic loss of connexin 43 (Cx43) from the cells as visualized by Western blotting. Substances with the ability to inhibit Cx43-dependent GJIC have previously been observed to interfere with normal hematopoietic development. The ability of benzene metabolites to interfere with gap-junction functionality, and especially the dramatic loss of Cx43 induced by MUC, should therefore be considered as a possible mechanism for benzene-induced hematotoxicity and development of leukemia. FAU - Rivedal, Edgar AU - Rivedal E AD - Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310, Oslo, Norway. edgarr@labmed.uio.no FAU - Witz, Gisela AU - Witz G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20050203 PL - Germany TA - Arch Toxicol JT - Archives of toxicology JID - 0417615 RN - 0 (Connexin 43) RN - EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinases) RN - J64922108F (Benzene) SB - IM MH - Animals MH - Benzene/metabolism/*toxicity MH - Blotting, Western MH - Cell Communication/*drug effects MH - Cell Line MH - Connexin 43/metabolism MH - Epithelial Cells/cytology/*drug effects MH - Gap Junctions/*drug effects MH - Liver/cytology MH - Mitogen-Activated Protein Kinase Kinases/metabolism MH - Rats EDAT- 2005/02/04 09:00 MHDA- 2005/10/18 09:00 CRDT- 2005/02/04 09:00 PHST- 2004/07/14 00:00 [received] PHST- 2004/11/10 00:00 [accepted] PHST- 2005/02/04 09:00 [pubmed] PHST- 2005/10/18 09:00 [medline] PHST- 2005/02/04 09:00 [entrez] AID - 10.1007/s00204-004-0638-0 [doi] PST - ppublish SO - Arch Toxicol. 2005 Jun;79(6):303-11. doi: 10.1007/s00204-004-0638-0. Epub 2005 Feb 3.